YMAB Y-mAbs Therapeutics Inc: Sotuvning sof marjinal rentabelligi

ymabs.com (YMAB) tovar belgisi

Y-mAbs Therapeutics (YMAB) olimlarining sodiqligi bolalar saratonini yengishga bo'lgan intilishga asoslangan, biroq daromad birligiga to'g'ri keladigan sof foyda ushbu jarayonlarning beqarorligini ko'rsatmoqda. -26.00 qiymati eng so'nggi metrika qiymatini aks ettiradi. Barqarorlik inqirozlardan qat'i nazar, kritik patologiyalar uchun sug'urta qoplamasi bilan kafolatlanadi, terapevtik analoglarning yo'qligi esa kompaniyaga davolash xarajatlarini imkon qadar yuqori darajada belgilash uchun sezilarli narx belgilash imkoniyatidan foydalanishga imkon beradi.

ymabs.com (YMAB) Kompaniya sotuv marjasi: 04.07.2022 - 27.09.2025 davri uchun

YmAbs - tahliliy kesimlar va asosiy koʻrsatkichlar (YMAB)

- aksiya kursi va ekspertlarning narx prognozi:
- kompaniya aksiyalari kapitallashuvi ma'lumotlari:
Kompaniyaning jamlanma tahliliyoti:Y-mAbs Corp - YMAB
Y-mAbs Therapeutics Inc tayyor mahsulotlari

Noyob onkologik davolash usullari uchun eksklyuziv patent huquqlariga ega bo'lgan Y-mAbs Therapeutics (YMAB) generik raqobatdan himoyalangan bo'lib, bu bevosita monetizatsiya samaradorligiga ta'sir qiladi. Sof foyda marjasi grafigining tahlili daromadning har bir dollari uchun foyda ulushini baholash imkonini beradi, bu esa biznesning haqiqiy chidamliligini va hatto pessimistik bozor ssenariylarida ham kompaniyaning moliyaviy zaxirasini ochib beradi.

Raqobatdosh kompaniyalar tahlili

ONC: Sotuvning sof marjinal rentabelligi|Sof marja Halozyme Inc. (HALO)|Sof marja RevMed|Sotuvning sof rentabelligi AAPG (Ascentage Pharma Group)|Sotuvning sof marjinal rentabelligi CGON|UroGen Pharma - Sotuvning sof rentabelligi|Bicara Therapeutics - Sof foyda bo'yicha sotuv rentabelligi|Sotuvning sof marjinal rentabelligi Personalis Inc PSNL|Erasca Oncology - Sotuvning sof marjinal rentabelligi|Sof foyda normasi DCTH (Delcath Corp)|aurabiosciences.com (AURA) - Sof marja|Candel Therapeutics Inc. - Sof foyda normasi|Sof marja Accuray Inc.|Sof marja SELLAS Life Sciences Group SLS|Sotuvning sof marjinal rentabelligi ACTU|CTOR - Sof marja|Sotuvning sof marjinal rentabelligi HURA (TuHURA Biosciences, Inc.)|Sof foyda normasi TARA|FATE: Sof foyda bo'yicha sotuv rentabelligi|WHWK (aadibio.com) - Sotuvning sof rentabelligi|TCRX (TScan Therapeutics, Inc.) - Sof foyda bo'yicha sotuv rentabelligi|Sof marja Champions Oncology Corp (CSBR)|XBIT (XBiotech Inc.) - Sotuvning sof marjinal rentabelligi|CVM (CEL-SCI Corporation) - Kompaniyaning sof rentabelligi|Sotuvning sof marjinal rentabelligi OSTX|Sotuvning sof marjinal rentabelligi Radiopharm Theranostics Ltd (RADX)|Sotuvning sof marjinal rentabelligi ARTV (Artiva Biotherapeutics)|Sotuvning sof marjinal rentabelligi Adlai Nortye Ltd. ANL|Veru Inc - Sotuvning sof marjinal rentabelligi|Kompaniya sotuv marjasi Tempest Therapeutics TPST|XLO: Sotuvning sof marjinal rentabelligi|Enochian BioSciences (RENB) - Sotuvning sof marjinal rentabelligi|Sof foyda bo'yicha sotuv rentabelligi MURA|Kairos Pharma Ltd - Sof foyda marjasi|Sotuvning sof marjinal rentabelligi OKUR|CytoMed Therapeutics Limited (GDTC) - Sof foyda bo'yicha marjinallik|Sotuvning sof marjinal rentabelligi CRIS (Curis, Inc.)|APLM: Sotuvning sof rentabelligi|Tharimmune Corporation - Sotuvning sof marjinal rentabelligi|ADVB: Sof marja|GNPX: Sotuvning sof marjinal rentabelligi|CLDI (Calidi Biotherapeutics Inc.) - Sof marja|Sof marja Sunshine Biopharma, Inc.|Sotuvning sof marjinal rentabelligi xeneticbio.com|Sof marja Salarius (SLRX)|Sof foyda bo'yicha sotuv rentabelligi Purple Biotech PPBT|Sof marja American Oncology Network, Inc. AONC|BeiGene, Ltd. (BGNE) - Sof marja|Checkpoint Therapeutics Inc. - Sotuvning sof marjinal rentabelligi|Sof foyda normasi ELEV (Elevation Oncology)|ICAD (iCAD Corp) - Sof foyda bo'yicha sotuv rentabelligi|Ikena Oncology, Inc. - Sof foyda normasi|Sof foyda bo'yicha sotuv rentabelligi NTBL|VIRX: Sof foyda normasi|Sof marja MorphoSys Corporation (MOR)|NAYA - Sof marja|Sotuvning sof marjinal rentabelligi AAPGV (Ascentage)